Characteristics of control subjects and subjects with schizophrenia.

665: Min (12.9) Max (43.2) Avg (28.1) **One Pair Not Shown: HU 1201 (C) and 1189 (S) 802: Min (19.9) Max (37.9) Avg (29) 1222: Min (18.6) Max (43) Avg (30.8)
All subject pairs shown were included in analyses of PAK1 and kalirin protein levels. Subject pairs also analyzed for spinophilin protein levels (Observed PMI≤24 hours) are indicated by an asterisk. Control and schizophrenia subjects significantly differed in pH and handedness, but not in age, sex, PMI, and tissue storage time. S/R/A, Sex/Race/Age; PMI, postmortem interval (calculated as lag from midpoint of time last seen alive – time discovered dead to time of brain fixation. [Observed] is calculated as time discovered dead to time of brain fixation); COD, cause of death; Hand, handedness; Meds ATOD, medications used at time of death; ADC, Alcohol Dependence, current at time of death; ADR, Alcohol Dependence, in remission at time of death; AAC, Alcohol Abuse, current at time of death; AAR, Alcohol Abuse, in remission at time of death; ODC, Other Substance Dependence, current at time of death; ODR, Other Substance Dependence, in remission at time of death; OAC, Other Substance Abuse, current at time of death; OAR, Other Substance Abuse, in remission at time of death; L, Left; M, Mixed; R, Right; U, Unknown; B, Benzodiazepines; C, Anticonvulsants; D, Antidepressants; L, Lithium; N, No medications; O, Other medication(s); P,Antipsychotic; U, Unknown.